Relationship between microtubule-binding repeats and morphology of neurofibrillary tangle in Alzheimer's disease

Acta Neurologica Scandinavica

Volumn 112, Issue 5, 2005, Pages 327-334

  Kitamura, T ^a,b   Sugimori, K ^b   Sudo, S ^c   Kobayashi, K ^b  

^a Ishikawa Prefectural Takamatsu Hospital   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^c UNIVERSITY OF FUKUI   (Japan)

Author keywords

Alzheimer's disease; Immunohistochemistry; Neurofibrillary tangles; Tau isoform

Indexed keywords

TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MICROTUBULE ASSEMBLY; MOLECULAR RECOGNITION; NEUROFIBRILLARY TANGLE; SUBICULUM; TANDEM REPEAT;

ADULT; AGED; ALZHEIMER DISEASE; BINDING SITES; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MICROSATELLITE REPEATS; MICROTUBULES; MIDDLE AGED; NEUROFIBRILLARY TANGLES; NEUROFIBRILS; REPETITIVE SEQUENCES, NUCLEIC ACID; STATISTICS; TAU PROTEINS; TRINUCLEOTIDE REPEATS;

EID: 27444446184     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2005.00488.x     Document Type: Article

References (30)

1. BRAAK H, BRAAK E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82:239-59.
2. ARRIAGADA PV, GROWDON JH, HEDLEY-WHYTE ET, HYMAN BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992;42:631-9.
3. WEINGARTEN MD, LOCKWOOD AH, HWO SY, KIRSCHNER MW. A protein factor essential for microtubule assembly. Proc Natl Acad Sci USA 1975;72:1858-62.
4. GOEDERT M, SPILLANTINI MG, JAKES R, RUTHERFORD D, CROWTHER RA. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 1989;3:519-26.
5. LEE G, NEVE RL, KOSIK KS. The microtubule binding domain of tau protein. Neuron 1989;2:1615-24.
6. GOEDERT M, JAKES R, SPILLANTINI MG, HASEGAWA M, SMITH MJ, CROWTHER RA. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 1996;383:550-3.
7. DELACOURTE A, FLAMENT S, DIBE EM et al. Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease. Demonstration with a panel of antibodies against tau proteins. Acta Neuropathol (Berl) 1990;80:111-7.
8. BUÉE L, DELACOURTE A. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease. Brain Pathol 1999;9: 681-93.
9. MAILLIOT C, BUSSIERE T, HAMDANE M et al. Pathological tau phenotypes. The weight of mutations, polymorphisms, and differential neuronal vulnerabilities. Ann N Y Acad Sci 2000;920:107-14.
10. ARAI T, IKEDA K, AKIYAMA H et al. Distinct isoforms of tau aggregated in neurons and glial cells brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol (Berl) 2001;101: 167-73.
11. DE SILVA R, LASHLEY T, GIBB G et al. Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathol Appl Neurobiol 2003;29:288-302.
12. TOGO T, AKIYAMA H, ISEKI E et al. Immunohistochemical study of tau accumulation in early stages of Alzheimer-type neurofibrillary lesions. Acta Neuropathol (Berl) 2004;107:504-8.
13. SU JH, CUMMINGS BJ, COTMAN CW. Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neuntes. Neuroreport 1994;5: 2358-62.
14. NAKANO H, KOBAYASHI K, SUGIMORI K et al. Regional analysis of differently phosphorylated tau proteins in brains from patients with Alzheimer's disease. Dement Geriatr Cogn Disord 2004;17:122-31.
15. AUGUSTINACK JC, SCHNEIDER A, MANDELKOW EM, HYMAN BT. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol (Berl) 2002;103:26-35.
16. LAUCKNER J, FREY P, GEULA C. Comparative distribution of tau phosphorylated at Ser262 in pre-tangles and tangles. Neurobiol Aging 2003;24:767-76.
17. BRAAK E, BRAAK H, MANDELKOW EM. A sequence of cytoskeletal changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol (Berl) 1994;87:554-67.
18. UCHIHARA T, NAKAMURA A, YAMAZAKI M, MORI O. Evolution from pretangle neurons to neurofibrillary tangles monitored by thiazin red combined with Gallyas method and double immunofluorescence. Acta Neuropathol (Berl) 2001;101:535-9.
19. KOBAYASHI K, HAYASHI M, NAKANO H et al. Apoptosis of astrocytes with enhanced lysosomal activity and oligodendrocytes in white matter lesions in Alzheimer's disease. Neuropathol Appl Neurobiol 2002;28:238-51.
20. KOBAYASHI K, NAKANO H, HAYASHI M et al. Association of phosphorylation site of tau protein with neuronal apoptosis in Alzheimer's disease. J Neurol Sci 2003;208:17-24.
21. MIRRA SS, HEYMAN A, MCKEEL D et al. The Consortium to Establish a Registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-86.
22. YAMADA M, ITOH Y, SODEYAMA N et al. Senile dementia of the neurofibrillary tangle type: a comparison with Alzheimer's disease. Dement Geriatr Cogn Disord 2001;12:117-26.
23. TAKAYAMA N, ISEKI E, YAMAMOTO T, KOSAKA K. Regional quantitative study of formation process of neurofibrillary tangles in the hippocampus of non-demented elderly brains: comparison with late-onset Alzheimer's disease brains. Neuropathology 2002;22:147-53.
24. ISEKI E, TSUNODA S, SUZUKI K et al. Regional quantitative analysis of NFT in brains of non-demented elderly persons: comparisons with findings in brains of late-onset Alzheimer's disease and limbic NFT dementia. Neuropathology 2002;22:34-9.
25. BUSSIÈRE T, HOF PR, MAILLIOT C et al. Phosphorylated serine422 on tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration. Acta Neuropathol (Berl) 1999;97:221-30.
26. ISHIZAWA T, Ko LW, COOKSON N, DAVIAS P, ESPINOZA M, DICKSON DW. Selective neurofibrillary degeneration of the hippocampal CA2 sector is associated with four-repeat tauopathics. J Neuropathol Exp Neurol 2002;61:1040-7.
27. GROVER A, HOULDENT H, BAKER M et al. 5′ splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10. J Biol Chem 1999;274:15134-43.
28. ZHUKAREVA V, MANN D, PICKERING-BROWN S et al. Sporadic Pick's disease: a tauopathy characterized by a spectrum of pathological tau isoforms in gray and white matter. Ann Neurol 2002;51:730-9.
29. ARAI T, IKEDA K, AKIYAMA H et al. Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol (Berl) 2003;105:489-98.
30. FERRER I, BARRACHINA M, PUIG B. Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyperphosphorylated tau deposits in tauopathics including Pick bodies and argyrophilic grains. Acta Neuropathol (Berl) 2002;104:658-64.